Patients with chronic kidney disease (CKD) who receive a gadolinium-based contrast agent (GBCA) have a low risk of developing nephrogenic systemic fibrosis (NSF), a systematic review and meta-analysis ...
Nephrogenic systemic fibrosis (NSF) was first described in 2000 as a scleromyxedema-like illness that presented with cutaneous fibrosis in 14 patients receiving chronic hemodialysis (Cowper et al, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results